default author photo

Zhong-Yu Hu

Government of the People's Republic of China - National Institutes for Food and Drug Control

China

  • Government of the People's Republic of China - National Institutes for Food and Drug Control

SCHOLARLY PAPERS

1

DOWNLOADS

67

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Safety, Tolerability, and Immunogenicity of a CpG/Alum Adjuvanted SARS-CoV-2 Recombinant Protein Vaccine (ZR202-CoV) in Healthy Adults: Preliminary Report of a Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial

Number of pages: 21 Posted: 06 Mar 2023
Ke Li, Zhongfang Wang, Peng He, Guang-Wei Feng, Qin-Ying Lan, Ling Ni, Ya-Zheng Yang, Chenfei Wang, Ting-Ting Cui, Lili Huang, Jin-Tao Gao, Zhiwei Jiang, Qing Yang, Bang-Wei Yu, Xi Han, Jing-Jing Chen, Shu-Yuan Yang, Lin Yuan, Ling-Yun Zhou, Zhen Huang, Zhiqiang Xie, Jincun Zhao, Zhong-Yu Hu and Ke Li
Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Government of the People's Republic of China - National Institutes for Food and Drug Control, Henan Provincial Center for Disease Control Prevention, Shanghai Zerun Biotechnology Co. LTD., Tsinghua University, Tsinghua University, National Institute for Food and Drug Control, Guangzhou Medical University - Guangzhou Institute of Respiratory Health, Henan Provincial Center for Disease Control Prevention, Xiangcheng County Center for Disease Control and Prevention, Beijing Key Tech Statistics Technology Co., Ltd., Shanghai Zerun Biotechnology Co. LTD., Shanghai Zerun Biotechnology Co. LTD., Shanghai Zerun Biotechnology Co. LTD., Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Walvax Biotechnology Co Ltd, Walvax Biotechnology Co Ltd, Shanghai Zerun Biotechnology Co. LTD., Walvax Biotechnology Co Ltd, Henan Provincial Center for Disease Control Prevention, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Government of the People's Republic of China - National Institutes for Food and Drug Control and Shanghai Zerun Biotechnology Co. LTD.
Downloads 67 (899,324)

Abstract:

Loading...

COVID-19, SARS-CoV-2 vaccine, Safety, Immunogenicity, Placebo-controlled, Clinical trial